Retension Pharmaceuticals, Inc. (RTSN)
Retension Pharmaceuticals Market Cap : 84.10M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 84.49M |
| November 04, 2026 | 91.39M |
| November 03, 2026 | 92.92M |
| November 02, 2026 | 89.06M |
| October 30, 2026 | 89.54M |
| October 29, 2026 | 93.24M |
| October 28, 2026 | 103.17M |
| October 27, 2026 | 106.56M |
| October 26, 2026 | 112.23M |
| October 23, 2026 | 120.19M |
| October 22, 2026 | 122.16M |
| Date | Value |
|---|---|
| October 21, 2026 | 118.22M |
| October 20, 2026 | 127.52M |
| October 19, 2026 | 128.71M |
| October 16, 2026 | 110.89M |
| October 15, 2026 | 96.23M |
| October 14, 2026 | 91.74M |
| October 13, 2026 | 91.66M |
| October 12, 2026 | 89.22M |
| October 09, 2026 | 82.99M |
| October 08, 2026 | 94.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AbbVie, Inc. | 508.34B |
| Abeona Therapeutics, Inc. | 232.91M |
| America Great Health | 2.115M |
| Acumen Pharmaceuticals, Inc. | 15.64M |
| Aardvark Therapeutics, Inc. | 25.60M |
Market Cap Related Metrics
| Price | 10.67 |
| Earnings Yield | -11.19% |